TY - JOUR
T1 - Trends of Exposure to Acrylamide as Measured by Urinary Biomarkers Levels within the HBM4EU Biomonitoring Aligned Studies (2000–2021)
AU - Poteser, Michael
AU - Laguzzi, Federica
AU - Schettgen, Thomas
AU - Vogel, Nina
AU - Weber, Till
AU - Murawski, Aline
AU - Schmidt, Phillipp
AU - Rüther, Maria
AU - Kolossa-Gehring, Marike
AU - Namorado, Sónia
AU - Nieuwenhuyse, An Van
AU - Appenzeller, Brice
AU - Dufthaksdóttir, Edda
AU - Olafsdóttir, Kristín
AU - Haug, Line Småstuen
AU - Thomsen, Cathrine
AU - Barbone, Fabio
AU - Rosolen, Valentina
AU - Rambaud, Loïc
AU - Riou, Margaux
AU - Göen, Thomas
AU - Nübler, Stefanie
AU - Schäfer, Moritz
AU - Zarrabi, Karin H.A.
AU - Gilles, Liese
AU - Martin, Laura Rodriguez
AU - Schoeters, Greet
AU - Sepai, Ovnair
AU - Govarts, Eva
AU - Moshammer, Hanns
N1 - Funding Information:
This work received external funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No. 733032 and received co-funding from the author’s organizations. The Norwegian Institute of Public Health (NIPH) contributed to the funding of the Norwegian Environmental Biobank (NEB). The laboratory measurements were partly funded by the Research Council of Norway through research projects (275903 and 268465).
Funding Information:
The authors acknowledge all the participating and expert laboratories involved, including the HBM4EU QA/QC program, the Management and Advisory Boards of HBM4EU, and the funding received from the European Union’s Horizon 2020 research and innovation program (grant agreement No 733032).
Publisher Copyright:
© 2022 by the authors.
PY - 2022/8/2
Y1 - 2022/8/2
N2 - Acrylamide, a substance potentially carcinogenic in humans, represents a very prevalent contaminant in food and is also contained in tobacco smoke. Occupational exposure to higher concentrations of acrylamide was shown to induce neurotoxicity in humans. To minimize related risks for public health, it is vital to obtain data on the actual level of exposure in differently affected segments of the population. To achieve this aim, acrylamide has been added to the list of substances of concern to be investigated in the HBM4EU project, a European initiative to obtain biomonitoring data for a number of pollutants highly relevant for public health. This report summarizes the results obtained for acrylamide, with a focus on time-trends and recent exposure levels, obtained by HBM4EU as well as by associated studies in a total of seven European countries. Mean biomarker levels were compared by sampling year and time-trends were analyzed using linear regression models and an adequate statistical test. An increasing trend of acrylamide biomarker concentrations was found in children for the years 2014–2017, while in adults an overall increase in exposure was found to be not significant for the time period of observation (2000–2021). For smokers, represented by two studies and sampling for, over a total three years, no clear tendency was observed. In conclusion, samples from European countries indicate that average acrylamide exposure still exceeds suggested benchmark levels and may be of specific concern in children. More research is required to confirm trends of declining values observed in most recent years.
AB - Acrylamide, a substance potentially carcinogenic in humans, represents a very prevalent contaminant in food and is also contained in tobacco smoke. Occupational exposure to higher concentrations of acrylamide was shown to induce neurotoxicity in humans. To minimize related risks for public health, it is vital to obtain data on the actual level of exposure in differently affected segments of the population. To achieve this aim, acrylamide has been added to the list of substances of concern to be investigated in the HBM4EU project, a European initiative to obtain biomonitoring data for a number of pollutants highly relevant for public health. This report summarizes the results obtained for acrylamide, with a focus on time-trends and recent exposure levels, obtained by HBM4EU as well as by associated studies in a total of seven European countries. Mean biomarker levels were compared by sampling year and time-trends were analyzed using linear regression models and an adequate statistical test. An increasing trend of acrylamide biomarker concentrations was found in children for the years 2014–2017, while in adults an overall increase in exposure was found to be not significant for the time period of observation (2000–2021). For smokers, represented by two studies and sampling for, over a total three years, no clear tendency was observed. In conclusion, samples from European countries indicate that average acrylamide exposure still exceeds suggested benchmark levels and may be of specific concern in children. More research is required to confirm trends of declining values observed in most recent years.
KW - acrylamide
KW - exposure level
KW - glycidamide
KW - HBM4EU
KW - time-trend
UR - http://www.scopus.com/inward/record.url?scp=85137353796&partnerID=8YFLogxK
UR - https://pubmed.ncbi.nlm.nih.gov/36006122
U2 - 10.3390/toxics10080443
DO - 10.3390/toxics10080443
M3 - Article
C2 - 36006122
SN - 2305-6304
VL - 10
JO - Toxics
JF - Toxics
IS - 8
M1 - 443
ER -